binding and CD94/NKG2 receptor engagement, human leucocyte antigen E (HLA-E) reports
cellular health to NK cells. Previous studies demonstrated a strong bias for VL9 binding by
HLA-E, a preference subsequently supported by structural analyses. However, Mycobacteria
tuberculosis (Mtb) infection and Rhesus cytomegalovirus-vectored SIV vaccinations
revealed contexts where HLA-E and the rhesus homologue, Mamu-E, presented diverse …